Laboratory Automation - only the white coats remain
Reducing the time and cost of clinical tests will help us beat the big killers, then guide our personalised rejuvenation programmes
Join the club for FREE to access the whole archive and other member benefits.
It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Interesting Engineering - 25-Jan-2024
Autonomous robot outperforms scientists, accelerating the path to new pharmaceuticals
Read more...Live Forever Club - 18-Jan-2024
FAST is precise and works with different cell types and microscopes
Read more...Longevity Technology - 22-Nov-2023
Offers over 20 innovative organ models for realistic testing and collaborating
Read more...Live Forever Club - 20-Nov-2023
The research could lead to new ways to slow down ageing in humans
Read more...Click on resource name for more details.
Biotechnology company that combines experience in ageing research, the nematode C. elegans and automation
Company focused on the discovery and development of therapies for patients with neurodegenerative diseases
Biotechnology company that develops and manufactures human therapeutics for various illness and diseases
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing microbiome research
Company developing, producing and marketing affordable, high quality generic drugs and specialty pharmaceuticals
Reducing the time and cost of clinical tests will help us beat the big killers, then guide our personalised rejuvenation programmes